articleNew England Journal of MedicineAug 9, 2006BRONZE OA

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

TSThe Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators

Délégation Paris 7 · Université Paris Cité

PubMed
Indexed incrossrefpubmed

Abstract

Background

Statins reduce the incidence of strokes among patients at increased risk for cardiovascular disease; whether they reduce the risk of stroke after a recent stroke or transient ischemic attack (TIA) remains to be established.

Methods

We randomly assigned 4731 patients who had had a stroke or TIA within one to six months before study entry, had low-density lipoprotein (LDL) cholesterol levels of 100 to 190 mg per deciliter (2.6 to 4.9 mmol per liter), and had no known coronary heart disease to double-blind treatment with 80 mg of atorvastatin per day or placebo. The primary end point was a first nonfatal or fatal stroke.

Citation impact

2,881
total citations
FWCI
180.56
Percentile
100%
References
21
Citations per year

Authors

1
  • TS
    The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) InvestigatorsCorresponding

    Délégation Paris 7, Université Paris Cité

Topics & keywords

Keywords
  • Medicine
  • Atorvastatin
  • Hazard ratio
  • Stroke (engine)
  • Placebo
  • Confidence interval
  • Internal medicine
  • Liter
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding